|
|
Line 131: |
Line 131: |
| |width=100px|{{#pwImage:Pathway:WP5031|250px||Biotin Metabolism (including IEMs) (Homo sapiens)}} | | |width=100px|{{#pwImage:Pathway:WP5031|250px||Biotin Metabolism (including IEMs) (Homo sapiens)}} |
| |width=100px|{{#pwImage:Pathway:WP5037|250px||Riboflavin and CoQ disorders (Homo sapiens)}} | | |width=100px|{{#pwImage:Pathway:WP5037|250px||Riboflavin and CoQ disorders (Homo sapiens)}} |
- | |}
| |
- | ===December 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP5019|250px||Acetogenesis (Acetobacterium woodii)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4969|250px||RAS and Bradykinin pathways in COVID-19 (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4970|250px||Galanin receptor pathway (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4874|250px||CAMKK2 Pathway (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4961|250px||STING pathway in Kawasaki-like disease and COVID-19 (Homo sapiens)}}
| |
- | |}
| |
- | ===November 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP4965|250px||Deregulation of the Renin Angiotensin system by Sars-CoV infection (Mus musculus)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4949|250px||16p11.2 proximal deletion syndrome (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4846|250px||SARS-CoV-2 and COVID-19 Pathway (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4707|250px||aspirin and miRNAs (Homo sapiens)}}
| |
- | |}
| |
- | ===October 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP2880|250px||Glucocorticoid Receptor Pathway (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4932|250px||7q11.23 copy number variation syndrome (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4946|250px||DNA Repair Pathways Full Network (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4950|250px||16p11.2 distal deletion syndrome (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4963|250px||p53 transcriptional gene network (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4966|250px||Fluoroacetic acid toxicity (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4971|250px||Phosphoinositides metabolism (Homo sapiens)}}
| |
- | |}
| |
- | ===September 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP2253|250px||}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4942|250px||}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4816|250px||}}
| |
- | |}
| |
- | ===August 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP471|250px||Beta Oxidation of Unsaturated Fatty Acids (Caenorhabditis elegans)}}
| |
- | |}
| |
- | ===July 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP4928|250px||MAPK pathway in congenital thyroid cancer (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4940|250px||15q11.2 copy number variation syndrome (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4944|250px||Mitochondrial Complex I inhibition leading to chemical induced fanconi syndrome (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4947|250px||NO metabolism in cystic fibrosis (Homo sapiens)}}
| |
- | |}
| |
- | ===June 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP4806|250px||EGFR Tyrosine Kinase Inhibitor Resistance (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4844|250px||The influence of laminopathies on Wnt signaling (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4853|250px||Linoleic acid metabolism known to be affected by coronavirus infection (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4861|250px||Endoplasmic reticulum (ER) stress response in Coronavirus infection (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4883|250px||SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor: Molecular mechanisms and potential therapeutic target (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4904|250px||LDLRAD4 and what we know about it (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4906|250px||3q29 copy number variation syndrome (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4927|250px||COVID-19, thrombosis and anticoagulation (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4931|250px||Direct Reversal Repair (Homo sapiens)}}
| |
- | |}
| |
- | ===May 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP4922|250px||Mitochondrial CIV Assembly (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4923|250px||Autophagy (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4925|250px||Unfolded protein response (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4872|250px||MAP3K1 role in promoting and blocking gonadal determination (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4918|250px||Cellular Proteostasis (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4919|250px||Neuroinflammation (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4920|250px||Mitochondrial CII Assembly (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4921|250px||Mitochondrial CIII assembly (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4900|250px||Purinergic signaling (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4905|250px||1q21.1 copy number variation syndrome (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4912|250px||SARS coronavirus and innate immunity (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4917|250px||Proximal tubule transport (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4814|250px||Somatic Sex determination (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4873|250px||Peroxiredoxin 2 induced ovarian failure (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4875|250px||Disruption of postsynaptic signalling by CNV (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4879|250px||Interacting Laminopathic Pathways (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4835|250px||Peroxiredoxin 2 induced ovarian failure (Mus musculus)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4842|250px||Mammalian disorder of sexual development (Homo sapiens)}}
| |
- | |}
| |
- | ===April 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP3890|250px||Nanomaterial-induced Inflammasome Activation (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4466|250px||Oxidative Stress and Redox Pathway (Mus musculus)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4799|250px||Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein. (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4803|250px||Ciliopathies (Homo sapiens))}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4804|250px||Cholesterol Biosynthesis with Skeletal Dysplasias (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4808|250px||Endochondral Ossification with Skeletal Dysplasias (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4815|250px||Glycosaminoglycan degradation (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4818|250px||Conversion of Angiotensinogen to Angiotensin II (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4820|250px||GDNF/RET signalling axis (Mus musculus)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4823|250px||Genes controlling renal nephrogenesis (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4838|250px||Regucalcin in proximal tubule epithelial kidney cells (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4891|250px||COVID-19 AOP (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4856|250px||Intracellular trafficking proteins involved in CMT neuropathy (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4860|250px||Hijack of Ubiquitination by SARS-CoV-2 (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4863|250px||Host-pathogen interaction of human corona viruses - autophagy (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4864|250px||Host-pathogen interaction of human corona viruses - apoptosis (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4868|250px||Type I Interferon Induction and Signaling During SARS-CoV-2 Infection (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4871|250px||Kisspeptin/Kisspeptin Receptor System in the Ovary (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4876|250px||Activation of NLRP3 Inflammasome by SARS-CoV-2 (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4884|250px||Pathogenesis of SARS-CoV-2 Mediated by nsp9/nsp10 Complex (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4877|250px||Host-pathogen interaction of human corona viruses - MAPK signaling (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4880|250px||Host-pathogen interaction of human corona viruses - Interferon induction (Homo sapiens)}}
| |
| |} | | |} |
| | | |
- | ===March 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP4784|250px||Proteoglycan biosynthesis (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4785|250px||Somitogenesis in the context of spondylocostal dysostosis (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4786|250px||Type I collagen synthesis in the context of Osteogenesis imperfecta (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4787|250px||Osteoblast differentiation (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4788|250px||Autosomal recessive Osteopetrosis pathways (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4789|250px||MED and Pseudoachondroplasia genes (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4790|250px||FGF23 signalling in Hypophosphatemic rickets (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4829|250px||mBDNF and proBDNF regulation of GABA neurotransmission (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4830|250px||GDNF/RET signalling axis (Homo sapiens)}}
| |
- | |}
| |
- |
| |
- | ===February 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP4767|250px||FGFR3 signalling in chondrocyte proliferation and terminal differentiation (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4792|250px||Purine metabolism (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4701|250px||Monoterpene Biosynthesis Pathway Genes in Mint (Homo sapiens)}}
| |
- | |}
| |
- | ===January 2020===
| |
- | {| style="margin: 10px; background-color:#E4EEF2"
| |
- | |width=100px|{{#pwImage:Pathway:WP4698|250px||Vitamin D-sensitive calcium signaling in depression (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4746|250px||Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4747|250px||Netrin-UNC5B signaling Pathway (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4752|250px||Base Excision Repair (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4753|250px||Nucleotide Excision Repair (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4754|250px||IL-18 signaling pathway (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4756|250px||Renin Angiotensin Aldosterone System (RAAS) (Homo sapiens)}}
| |
- | |width=100px|{{#pwImage:Pathway:WP4760|250px||PKC-gamma calcium signaling pathway in ataxia (Homo sapiens)}}
| |
- | |-
| |
- | |width=100px|{{#pwImage:Pathway:WP4763|250px||Regulation of Pgc1a expression by a Gsk3b-Tfeb signaling axis in skeletal muscle (Mus musculus)}}
| |
- | |}
| |
| | | |
| === Prior Years === | | === Prior Years === |
| + | * [[WikiPathways:NewPathwayReleases2020|2020]] |
| * [[WikiPathways:NewPathwayReleases2019|2019]] | | * [[WikiPathways:NewPathwayReleases2019|2019]] |
| * [[WikiPathways:NewPathwayReleases2018|2018]] | | * [[WikiPathways:NewPathwayReleases2018|2018]] |
| * [[WikiPathways:NewPathwayReleases2017|2017]] | | * [[WikiPathways:NewPathwayReleases2017|2017]] |